Abstract
Beta 2 adrenergic receptor (β2-AR)-agonists, widely used as bronchodilators, have demonstrated wide-spectrum anti-inflammatory properties in both immune and non-immune cells in various tissues. Their anti-inflammatory properties are mediated primarily, but not exclusively, via activation of the canonical β2-AR signaling pathway (β2-AR/cAMP/PKA). As non-canonical β2-AR signaling also occurs, several inconsistent findings on the anti-inflammatory effect of β2-agonists are notably present. Increasing amounts of evidence have unveiled the alternative mechanisms of the β2-AR agonists in protecting the tissues against injuries, i.e., by augmenting mitochondria biogenesis and SIRT1 activity, and by attenuating fibrotic signaling. This review mainly covers the basic mechanisms of the anti-inflammatory effects of β2-AR activation along with its limitations. Specifically, we summarized the role of β2-AR signaling in regulating kidney function and in mediating the progression of acute and chronic kidney diseases. Given their versatile protective effects, β2-agonists can be a promising avenue in the treatment of kidney diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ağaç D, Estrada LD, Maples R, Hooper LV, Farrar JD (2018) The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion. Brain Behav Immun 74:176–185. https://doi.org/10.1016/j.bbi.2018.09.004
Ananieva O, Darragh J, Johansen C, Carr JM, McIlrath J, Park JM, Wingate A, Monk CE, Toth R, Santos SG, Iversen L, Arthur JSC (2008) The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol 9:1028–1036. https://doi.org/10.1038/ni.1644
Anderson R, Visser SS, Ramafi G, Theron AJ (2000) Accelerated resequestration of cytosolic calcium and suppression of the pro-inflammatory activities of human neutrophils by CGS 21680 in vitro. Br J Pharmacol 130:717–724. https://doi.org/10.1038/sj.bjp.0703344
Anderson R, Theron AJ, Steel HC, Durandt C, Tintinger GR, Feldman C (2014) The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro. Mediators Inflamm 2014:1–9. https://doi.org/10.1155/2014/105420
Arif E, Solanki AK, Srivastava P, Rahman B, Fitzgibbon WR, Deng P, Budisavljevic MN, Baicu CF, Zile MR, Megyesi J, Janech MG, Kwon S-H, Collier J, Schnellmann RG, Nihalani D (2019) Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury. Kidney Int 96:656–673. https://doi.org/10.1016/j.kint.2019.03.023
Avni D, Ernst O, Philosoph A, Zor T (2010) Role of CREB in modulation of TNFα and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Mol Immunol 47:1396–1403. https://doi.org/10.1016/j.molimm.2010.02.015
Azeloglu EU, Hardy SV, Eungdamrong NJ, Chen Y, Jayaraman G, Chuang PY, Fang W, Xiong H, Neves SR, Jain MR, Li H, Ma’ayan A, Gordon RE, He JC, Iyengar R (2014) Interconnected network motifs control podocyte morphology and kidney function. Sci Signal 7:ra12. https://doi.org/10.1126/scisignal.2004621
Baillie GS, Sood A, McPhee I, Gall I, Perry SJ, Lefkowitz RJ, Houslay MD (2003) β-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates-adrenoceptor switching from Gs to Gi. Proc Natl Acad Sci 100:940–945. https://doi.org/10.1073/pnas.262787199
Baker JG (2010) The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors. Br J Pharmacol 160:1048–1061. https://doi.org/10.1111/j.1476-5381.2010.00754.x
Barnes PJ (1999) Effect of β agonists on inflammatory cells. J Allergy Clin Immunol 104:S10–S17. https://doi.org/10.1016/S0091-6749(99)70269-1
Black PH (2002) Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 16:622–653. https://doi.org/10.1016/S0889-1591(02)00021-1
Bleecker ER, Nelson HS, Kraft M, Corren J, Meyers DA, Yancey SW, Anderson WH, Emmett AH, Ortega HG (2010) β2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. Am J Respir Crit Care Med 181:676–687. https://doi.org/10.1164/rccm.200809-1511OC
Boivin V, Jahns R, Gambaryan S, Ness W, Boege F, Lohse MJ (2001) Immunofluorescent imaging of β1- and β2-adrenergic receptors in rat kidney. Kidney Int 59:515–531. https://doi.org/10.1046/j.1523-1755.2001.059002515.x
Borland G, Smith BO, Yarwood SJ (2009) EPAC proteins transduce diverse cellular actions of cAMP. Br J Pharmacol 158:70–86. https://doi.org/10.1111/j.1476-5381.2008.00087.x
Cameron RB, Beeson CC, Schnellmann RG (2016) Development of therapeutics that induce mitochondrial biogenesis for the treatment of acute and chronic degenerative diseases. J Med Chem 59:10411–10434. https://doi.org/10.1021/acs.jmedchem.6b00669
Cameron RB, Peterson YK, Beeson CC, Schnellmann RG (2017) Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol. Sci Rep 7:10578. https://doi.org/10.1038/s41598-017-11030-5
Cameron RB, Gibbs WS, Miller SR, Dupre TV, Megyesi J, Beeson CC, Schnellmann RG (2019) Proximal tubule β2-adrenergic receptor mediates formoterol-induced recovery of mitochondrial and renal function after ischemia-reperfusion injury. J Pharmacol Exp Ther 369:173–180. https://doi.org/10.1124/jpet.118.252833
Cantó C, Auwerx J (2012) Targeting sirtuin 1 to improve metabolism: all you need is NAD+? Pharmacol Rev 64:166–187. https://doi.org/10.1124/pr.110.003905
Cazzola M, Calzetta L, Matera MG (2011) β2-adrenoceptor agonists: current and future direction. Br J Pharmacol 163:4–17. https://doi.org/10.1111/j.1476-5381.2011.01216.x
Chandrasekar B, Marelli-Berg FM, Tone M, Bysani S, Prabhu SD, Murray DR (2004) β-Adrenergic stimulation induces interleukin-18 expression via β2-AR, PI3K, Akt, IKK, and NF-κB. Biochem Biophys Res Commun 319:304–311. https://doi.org/10.1016/j.bbrc.2004.04.185
Cianfrocca R, Tocci P, Semprucci E, Spinella F, Di Castro V, Bagnato A, Rosanò L (2014) β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. Life Sci 118:179–184. https://doi.org/10.1016/j.lfs.2014.01.078
de Ponte MC, Casare FAM, Costa-Pessoa JM, Cardoso VG, Malnic G, Mello-Aires M, Volpini RA, Thieme K, Oliveira-Souza M (2017) The role of β-Adrenergic overstimulation in the early stages of renal injury. Kidney Blood Press Res 42:1277–1289. https://doi.org/10.1159/000485931
de Rooij J, Zwartkruis FJT, Verheijen MHG, Cool RH, Nijman SMB, Wittinghofer A, Bos JL (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474–477. https://doi.org/10.1038/24884
DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) β-Arrestins and cell signaling. Annu Rev Physiol 69:483–510. https://doi.org/10.1146/annurev.physiol.69.022405.154749
DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77:75–197. https://doi.org/10.1152/physrev.1997.77.1.75
Donnelly LE, Tudhope SJ, Fenwick PS, Barnes PJ (2010) Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages. Eur Respir J 36:178–186. https://doi.org/10.1183/09031936.00158008
Engel G, Maurer R, Perrot K, Richardson BP (1985) β-Adrenoceptor subtypes in sections of rat and guinea-pig kidney. Naunyn Schmiedebergs Arch Pharmacol 328:354–357. https://doi.org/10.1007/BF00515567
Farmer P, Pugin J (2000) β-Adrenergic agonists exert their “anti-inflammatory” effects in monocytic cells through the IκB/NF-κB pathway. Am J Physiol Cell Mol Physiol 279:L675–L682. https://doi.org/10.1152/ajplung.2000.279.4.L675
Flamand N, Surette ME, Picard S, Bourgoin S, Borgeat P (2002) Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils. Mol Pharmacol 62:250–256. https://doi.org/10.1124/mol.62.2.250
Gao H, Sun Y, Wu Y, Luan B, Wang Y, Qu B, Pei G (2004) Identification of β-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-κB pathways. Mol Cell 14:303–317. https://doi.org/10.1016/S1097-2765(04)00216-3
Gavrilyuk V, Dello Russo C, Heneka MT, Pelligrino D, Weinberg G, Feinstein DL (2002) Norepinephrine increases IκBα expression in astrocytes. J Biol Chem 277:29662–29668. https://doi.org/10.1074/jbc.M203256200
Gerhart-Hines Z, Dominy JE, Blättler SM, Jedrychowski MP, Banks AS, Lim J-H, Chim H, Gygi SP, Puigserver P (2011) The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD+. Mol Cell 44:851–863. https://doi.org/10.1016/j.molcel.2011.12.005
Gerlo S, Verdood P, Kooijman R (2010) Modulation of cytokine production by cyclic adenosine monophosphate analogs in human leukocytes. J Interfaces Cytokine Res 30:883–891. https://doi.org/10.1089/jir.2009.0021
Gesek FA, White KE (1997) Molecular and functional identification of beta-adrenergic receptors in distal convoluted tubule cells. Am J Physiol Physiol 272:F712–F720. https://doi.org/10.1152/ajprenal.1997.272.6.F712
Giembycz MA, Kaur M, Leigh R, Newton R (2009) A Holy Grail of asthma management: toward understanding how long-acting β2-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol 153:1090–1104. https://doi.org/10.1038/sj.bjp.0707627
Gloerich M, Bos JL (2010) Epac: Defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol 50:355–375. https://doi.org/10.1146/annurev.pharmtox.010909.105714
Grailer JJ, Haggadone MD, Sarma JV, Zetoune FS, Ward PA (2014) Induction of M2 regulatory macrophages through the β2-adrenergic receptor with protection during endotoxemia and acute lung injury. J Innate Immun 6:607–618. https://doi.org/10.1159/000358524
Hanania N, Moore R (2004) Anti-inflammatory activities of β2-agonists. Curr Drug Target Inflamm Allergy 3:271–277. https://doi.org/10.2174/1568010043343598
Herrmann FE, Wollin L, Wirth J, Gantner F, Lämmle B, Wex E (2017) Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis. Br J Pharmacol 174:3848–3864. https://doi.org/10.1111/bph.13982
Hizawa N (2011) Pharmacogenetics of β2-agonists. Allergol Int 60:239–246. https://doi.org/10.2332/allergolint.11-RAI-0317
Huber TB, Gloy J, Henger A, Schollmeyer P, Greger R, Mundel P, Pavenstadt H (1998) Catecholamines modulate podocyte function. J Am Soc Nephrol 9:335–345
Jesinkey SR, Funk JA, Stallons LJ, Wills LP, Megyesi JK, Beeson CC, Schnellmann RG (2014) Formoterol restores mitochondrial and renal function after ischemia-reperfusion injury. J Am Soc Nephrol 25:1157–1162. https://doi.org/10.1681/ASN.2013090952
Johnson M (2002) Effects of β2-agonists on resident and infiltrating inflammatory cells. J Allergy Clin Immunol 110:S282–S290. https://doi.org/10.1067/mai.2002.129430
Joshi T, Johnson M, Newton R, Giembycz MA (2015) The long-acting β 2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner. Br J Pharmacol 172:2634–2653. https://doi.org/10.1111/bph.13087
Kaur M, Chivers JE, Giembycz MA, Newton R (2008) Long-acting β2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol 73:203–214. https://doi.org/10.1124/mol.107.040121
Kaur M, Holden NS, Wilson SM, Sukkar MB, Chung KF, Barnes PJ, Newton R, Giembycz MA (2008) Effect of β2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Cell Mol Physiol 295:L505–L514. https://doi.org/10.1152/ajplung.00046.2008
Khalilimeybodi A, Daneshmehr A, Sharif-Kashani B (2018) Investigating β-adrenergic-induced cardiac hypertrophy through computational approach: classical and non-classical pathways. J Physiol Sci 68:503–520. https://doi.org/10.1007/s12576-017-0557-5
Kolmus K, Tavernier J, Gerlo S (2015) β2-Adrenergic receptors in immunity and inflammation: stressing NF-κB. Brain Behav Immun 45:297–310. https://doi.org/10.1016/j.bbi.2014.10.007
Kong Y, Ruan L, Qian L, Liu X, Le Y (2010) Norepinephrine promotes microglia to uptake and degrade amyloid β peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme. J Neurosci 30:11848–11857. https://doi.org/10.1523/JNEUROSCI.2985-10.2010
Krupnick JG, Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289–319. https://doi.org/10.1146/annurev.pharmtox.38.1.289
Lamkin DM, Ho H-Y, Ong TH, Kawanishi CK, Stoffers VL, Ahlawat N, Ma JCY, Arevalo JMG, Cole SW, Sloan EK (2016) β-Adrenergic-stimulated macrophages: comprehensive localization in the M1–M2 spectrum. Brain Behav Immun 57:338–346. https://doi.org/10.1016/j.bbi.2016.07.162
Lefkowitz RJ (1998) G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 273:18677–18680. https://doi.org/10.1074/jbc.273.30.18677
Lorton D, Bellinger D (2015) Molecular mechanisms underlying β-adrenergic receptor-mediated cross-talk between sympathetic neurons and immune cells. Int J Mol Sci 16:5635–5665. https://doi.org/10.3390/ijms16035635
Luttrell LM, Gesty-Palmer D (2010) Beyond desensitization : physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62:305–330. https://doi.org/10.1124/pr.109.002436
MacKenzie SJ, Baillie GS, McPhee I, MacKenzie C, Seamons R, McSorley T, Millen J, Beard MB, Heeke G, Houslay MD (2002) Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1). Br J Pharmacol 136:421–433. https://doi.org/10.1038/sj.bjp.0704743
Malerba M, Radaeli A, Morjaria JB (2012) Therapeutic potential for novel ultra long-acting β2-agonists in the management of COPD: biological and pharmacological aspects. Drug Discov Today 17:496–504. https://doi.org/10.1016/j.drudis.2011.11.002
Meng X-M, Nikolic-Paterson DJ, Lan HY (2014) Inflammatory processes in renal fibrosis. Nat Rev Nephrol 10:493–503. https://doi.org/10.1038/nrneph.2014.114
Millman EE, Rosenfeld JL, Vaughan DJ, Nguyen J, Dai W, Alpizar-Foster E, Clark RB, Knoll BJ, Moore RH (2004) Endosome sorting of β2 -adrenoceptors is GRK5 independent. Br J Pharmacol 141:277–284. https://doi.org/10.1038/sj.bjp.0705504
Miura S, Kawanaka K, Kai Y, Tamura M, Goto M, Shiuchi T, Minokoshi Y, Ezaki O (2007) An increase in murine skeletal muscle peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) mRNA in response to exercise is mediated by β-adrenergic receptor activation. Endocrinology 148:3441–3448. https://doi.org/10.1210/en.2006-1646
Nakamura A (2004) β2-adrenoceptor activation attenuates endotoxin-induced acute renal failure. J Am Soc Nephrol 15:316–325. https://doi.org/10.1097/01.ASN.0000111247.76908.59
Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T (2001) Activation of β2-adrenoceptor prevents shiga toxin 2-induced TNF-α gene transcription. J Am Soc Nephrol 12:2288–2299
Nakamura A, Imaizumi A, Niimi R, Yanagawa Y, Kohsaka T, Johns EJ (2005) Adenoviral delivery of the β2-adrenoceptor gene in sepsis: a subcutaneous approach in rat for kidney protection. Clin Sci 109:503–511. https://doi.org/10.1042/CS20050088
Nakamura A, Niimi R, Yanagawa Y (2010) Protection from sepsis-induced acute renal failure by adenoviral-mediated gene transfer of β2-adrenoceptor. Nephrol Dial Transplant 25:730–737. https://doi.org/10.1093/ndt/gfp561
Negreiros-Lima GL, Lima KM, Moreira IZ, Jardim BLO, Vago JP, Galvão I, Teixeira LCR, Pinho V, Teixeira MM, Sugimoto MA, Sousa LP (2020) Cyclic AMP regulates key features of macrophages via PKA: recruitment, reprogramming and efferocytosis. Cells 9:128. https://doi.org/10.3390/cells9010128
Newton R, Giembycz MA (2016) Understanding how long-acting β2-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma—an update. Br J Pharmacol 173:3405–3430. https://doi.org/10.1111/bph.13628
Noh H, Yu MR, Kim HJ, Lee JH, Park B-W, Wu I-H, Matsumoto M, King GL (2017) Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications. Kidney Int 92:101–113. https://doi.org/10.1016/j.kint.2017.02.013
Oldenburger A, Roscioni SS, Jansen E, Menzen MH, Halayko AJ, Timens W, Meurs H, Maarsingh H, Schmidt M (2012) Anti-inflammatory role of the cAMP effectors Epac and PKA: implications in chronic obstructive pulmonary disease. PLoS ONE 7:e31574. https://doi.org/10.1371/journal.pone.0031574
Palmer CNA, Lipworth BJ, Lee S, Ismail T, Macgregor DF, Mukhopadhyay S (2006) Arginine-16 β2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax 61:940–944. https://doi.org/10.1136/thx.2006.059386
Park J, Shrestha R, Qiu C, Kondo A, Huang S, Werth M, Li M, Barasch J, Suszták K (2018) Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science 360:758–763. https://doi.org/10.1126/science.aar2131
Parnell E, Palmer TM, Yarwood SJ (2015) The future of EPAC-targeted therapies: agonism versus antagonism. Trends Pharmacol Sci 36:203–214. https://doi.org/10.1016/j.tips.2015.02.003
Roberts MJ, Broome RE, Kent TC, Charlton SJ, Rosethorne EM (2018) The inhibition of human lung fibroblast proliferation and differentiation by Gs-coupled receptors is not predicted by the magnitude of cAMP response. Respir Res 19:56. https://doi.org/10.1186/s12931-018-0759-2
Sands WA, Woolson HD, Milne GR, Rutherford C, Palmer TM (2006) Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells. Mol Cell Biol 26:6333–6346. https://doi.org/10.1128/MCB.00207-06
Saraiva M, O’Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170–181. https://doi.org/10.1038/nri2711
Sarir H, Mortaz E, Karimi K, Johnson M, Nijkamp FP, Folkerts G (2007) Combination of fluticasone propionate and salmeterol potentiates the suppression of cigarette smoke-induced IL-8 production by macrophages. Eur J Pharmacol 571:55–61. https://doi.org/10.1016/j.ejphar.2007.05.034
Scholpa NE, Simmons EC, Tilley DG, Schnellmann RG (2019) β2-adrenergic receptor-mediated mitochondrial biogenesis improves skeletal muscle recovery following spinal cord injury. Exp Neurol 322:113064. https://doi.org/10.1016/j.expneurol.2019.113064
Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, Reiter E, Premont RT, Lichtarge O, Lefkowitz RJ (2006) β-arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor. J Biol Chem 281:1261–1273. https://doi.org/10.1074/jbc.M506576200
Singh H, Linas S (1996) β2-Adrenergic function in cultured rat proximal tubule epithelial cells. Am J Physiol Physiol 271:F71–F77. https://doi.org/10.1152/ajprenal.1996.271.1.F71
Singh H, Linas SL (1997) Role of protein kinase C in β2-adrenoceptor function in cultured rat proximal tubule epithelial cells. Am J Physiol Physiol 273:F193–F199. https://doi.org/10.1152/ajprenal.1997.273.2.F193
Srivastava A, Gupta B, Gupta C, Shukla AK (2015) Emerging functional divergence of β-arrestin isoforms in GPCR function. Trends Endocrinol Metab 26:628–642. https://doi.org/10.1016/j.tem.2015.09.001
Steel HC, Tintinger GR, Theron AJ, Anderson R (2007) Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4. Clin Exp Immunol 150:144–150. https://doi.org/10.1111/j.1365-2249.2007.03470.x
Strohman MJ, Maeda S, Hilger D, Masureel M, Du Y, Kobilka BK (2019) Local membrane charge regulates β2 adrenergic receptor coupling to Gi3. Nat Commun 10:2234. https://doi.org/10.1038/s41467-019-10108-0
Summers RJ, Kuhar MJ (1983) Autoradiographic localization of β-adrenoceptors in rat kidney. Eur J Pharmacol 91:305–310. https://doi.org/10.1016/0014-2999(83)90484-3
Summers RJ, Stephenson JA, Kuhar MJ (1985) Localization of beta adrenoceptor subtypes in rat kidney by light microscopic autoradiography. J Pharmacol Exp Ther 232:561–569
Sun J, Lin X (2008) β-Arrestin 2 is required for lysophosphatidic acid-induced NF-κB activation. Proc Natl Acad Sci 105:17085–17090. https://doi.org/10.1073/pnas.0802701105
Swaney JS, Roth DM, Olson ER, Naugle JE, Meszaros JG, Insel PA (2005) Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc Natl Acad Sci 102:437–442. https://doi.org/10.1073/pnas.0408704102
Szelenyi J, Selmeczy Z, Brozik A, Medgyesi D, Magocsi M (2006) Dual β-adrenergic modulation in the immune system: Stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages. Neurochem Int 49:94–103. https://doi.org/10.1016/j.neuint.2006.01.009
Tan KS, Nackley AG, Satterfield K, Maixner W, Diatchenko L, Flood PM (2007) β2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-κB-independent mechanisms. Cell Signal 19:251–260. https://doi.org/10.1016/j.cellsig.2006.06.007
Taylor MRG (2007) Pharmacogenetics of the human beta-adrenergic receptors. Pharmacogenomics J 7:29–37. https://doi.org/10.1038/sj.tpj.6500393
Theron AJ, Steel H, Tintinger G, Feldman C, Anderson R (2013) Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting? Drug Des Devel Ther 7:1387. https://doi.org/10.2147/DDDT.S50995
Tintinger GR, Anderson R, Theron AJ, Ramafi G, Ker JA (2000) Comparison of the effects of selective and non-selective beta-adrenoreceptor agonists on the pro-inflammatory activities of human neutrophils in vitro. Inflammation 24:239–249. https://doi.org/10.1023/A:1007013530072
Tintinger G, Steel HC, Anderson R (2005) Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control. Clin Exp Immunol 141:191–200. https://doi.org/10.1111/j.1365-2249.2005.02800.x
Tintinger GR, Steel HC, Theron AJ, Anderson R (2008) Pharmacological control of neutrophil-mediated inflammation: Strategies targeting calcium handling by activated polymorphonuclear leukocytes. Drug Des Devel Ther 2:95–104
Tran TM, Friedman J, Qunaibi E, Baameur F, Moore RH, Clark RB (2004) Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of β 2-adrenergic receptor using phosphoserine-specific antibodies. Mol Pharmacol 65:196–206. https://doi.org/10.1124/mol.65.1.196
Trester-Zedlitz M, Burlingame A, Kobilka B, von Zastrow M (2005) Mass spectrometric analysis of agonist effects on posttranslational modifications of the β-2 adrenoceptor in mammalian cells. Biochemistry 44:6133–6143. https://doi.org/10.1021/bi0475469
Velmurugan BK, Baskaran R, Huang CY (2019) Detailed insight on β-adrenoceptors as therapeutic targets. Biomed Pharmacother 117:109039. https://doi.org/10.1016/j.biopha.2019.109039
Vergadi E, Ieronymaki E, Lyroni K, Vaporidi K, Tsatsanis C (2017) Akt signaling pathway in pacrophage activation and M1/M2 polarization. J Immunol 198:1006–1014. https://doi.org/10.4049/jimmunol.1601515
Victoni T, Salvator H, Abrial C, Brollo M, Porto LCS, Lagente V, Naline E, Grassin-Delyle S, Devillier P (2017) Human lung and monocyte-derived macrophages differ with regard to the effects of β2-adrenoceptor agonists on cytokine release. Respir Res 18:126. https://doi.org/10.1186/s12931-017-0613-y
Wang W, Xu M, Zhang Y, He B (2009) Fenoterol, a β2-adrenoceptor agonist, inhibits LPS-induced membrane-bound CD14, TLR4/CD14 complex, and inflammatory cytokines production through β-arrestin-2 in THP-1 cell line. Acta Pharmacol Sin 30:1522–1528. https://doi.org/10.1038/aps.2009.153
Wang S, Liu F, Tan KS, Ser H, Tan LT, Lee L, Tan W (2020) Effect of (R)-salbutamol on the switch of phenotype and metabolic pattern in LPS-induced macrophage cells. J Cell Mol Med 24:722–736. https://doi.org/10.1111/jcmm.14780
Watari K, Nakaya M, Kurose H (2014) Multiple functions of G protein-coupled receptor kinases. J Mol Signal 9:1. https://doi.org/10.1186/1750-2187-9-1
Webster AC, Nagler EV, Morton RL, Masson P (2017) Chronic kidney disease. Lancet 389:1238–1252. https://doi.org/10.1016/S0140-6736(16)32064-5
Wechsler ME, Lehman E, Lazarus SC, Lemanske RF, Boushey HA, Deykin A, Fahy JV, Sorkness CA, Chinchilli VM, Craig TJ, DiMango E, Kraft M, Leone F, Martin RJ, Peters SP, Szefler SJ, Liu W, Israel E (2006) β-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 173:519–526. https://doi.org/10.1164/rccm.200509-1519OC
Wechsler ME, Kunselman SJ, Chinchilli VM et al (2009) Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 374:1754–1764. https://doi.org/10.1016/S0140-6736(09)61492-6
Wen AY, Sakamoto KM, Miller LS (2010) The role of the transcription factor CREB in immune function. J Immunol 185:6413–6419. https://doi.org/10.4049/jimmunol.1001829
Xu Q, Dalic A, Fang L, Kiriazis H, Ritchie R, Sim K, Gao X-M, Drummond G, Sarwar M, Zhang Y-Y, Dart A, Du X-J (2011) Myocardial oxidative stress contributes to transgenic β2-adrenoceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol 162:1012–1028. https://doi.org/10.1111/j.1476-5381.2010.01043.x
Yeagley D, Quinn PG (2005) 3′,5′-Cyclic adenosine monophosphate response element-binding protein and CCAAT enhancer-binding protein are dispensable for insulin inhibition of phosphoenolpyruvate carboxykinase transcription and for its synergistic induction by protein kinase A and gl. Mol Endocrinol 19:913–924. https://doi.org/10.1210/me.2004-0281
Yin F, Wang Y-Y, Du J-H, Li C, Lu Z-Z, Han C, Zhang Y-Y (2006) Noncanonical cAMP pathway and p38 MAPK mediate β2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J Mol Cell Cardiol 40:384–393. https://doi.org/10.1016/j.yjmcc.2005.12.005
Acknowledgements
The preparation of this manuscript is supported by a research grant from Ewha Womans University (1-2020-0816-001-1).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dorotea, D., Ha, H. Activation of β2 adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases. Arch. Pharm. Res. 44, 49–62 (2021). https://doi.org/10.1007/s12272-020-01280-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-020-01280-9